J.R. Vilcoq

1.7k total citations
22 papers, 1.4k citations indexed

About

J.R. Vilcoq is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, J.R. Vilcoq has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 12 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in J.R. Vilcoq's work include Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Treatment and Pharmacology (4 papers). J.R. Vilcoq is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Treatment and Pharmacology (4 papers). J.R. Vilcoq collaborates with scholars based in France, Japan and United Kingdom. J.R. Vilcoq's co-authors include Alain Fourquet, Bernard Asselain, F. Campana, P Pouillart, J.C. Durand, Anne de la Rochefordière, Chantal Gautier, J Fenton, H Magdelénat and B Asselain and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J.R. Vilcoq

22 papers receiving 1.3k citations

Peers

J.R. Vilcoq
Jay R. Harris United States
J Vána United States
Jeffrey R. Harris United States
R. Amalric France
A P Locker United Kingdom
Jane Pettinga United States
H Brandone France
Jay R. Harris United States
J.R. Vilcoq
Citations per year, relative to J.R. Vilcoq J.R. Vilcoq (= 1×) peers Jay R. Harris

Countries citing papers authored by J.R. Vilcoq

Since Specialization
Citations

This map shows the geographic impact of J.R. Vilcoq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.R. Vilcoq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.R. Vilcoq more than expected).

Fields of papers citing papers by J.R. Vilcoq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.R. Vilcoq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.R. Vilcoq. The network helps show where J.R. Vilcoq may publish in the future.

Co-authorship network of co-authors of J.R. Vilcoq

This figure shows the co-authorship network connecting the top 25 collaborators of J.R. Vilcoq. A scholar is included among the top collaborators of J.R. Vilcoq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.R. Vilcoq. J.R. Vilcoq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hindié, Elif, David Groheux, Christophe Hennequin, et al.. (2011). Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 83(4). 1081–1088. 28 indexed citations
2.
Kirova, Youlia, J.R. Vilcoq, Bernard Asselain, et al.. (2005). Sarcomes radio-induits après cancer du sein : expérience de l'institut Curie et revue de la littérature. Cancer/Radiothérapie. 10(1-2). 83–90. 15 indexed citations
3.
Dendale, R., Anne Vincent‐Salomon, Alexia Savignoni, et al.. (2003). Medullary breast carcinoma: Prognostic implications of p53 expression. The International Journal of Biological Markers. 18(2). 99–105. 13 indexed citations
4.
Dendale, R., Anne Vincent‐Salomon, Alexia Savignoni, et al.. (2003). Medullary Breast Carcinoma: Prognostic Implications of P53 Expression. The International Journal of Biological Markers. 18(2). 99–105. 13 indexed citations
5.
Giraud, P., J.R. Vilcoq, F. Campana, Krishna B. Clough, & Alain Fourquet. (1996). PP-3-7 Long term time course of breast recurrence after breast-conservative treatment of small breast cancer. European Journal of Cancer. 32. 21–21. 2 indexed citations
6.
Rochefordière, Anne de la, Suzy Scholl, Philippe Broët, et al.. (1995). 142 Role of metachronous contralateral breast carcinoma in the outcome of breast cancer. International Journal of Radiation Oncology*Biology*Physics. 32. 212–212. 3 indexed citations
7.
Fourquet, Alain, et al.. (1995). 1076 Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer. International Journal of Radiation Oncology*Biology*Physics. 32. 260–260. 15 indexed citations
8.
Campana, F., Véronique Mosseri, Hélène Dreyfus, et al.. (1995). Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. International Journal of Radiation Oncology*Biology*Physics. 31(4). 783–789. 46 indexed citations
9.
Scholl, Suzy, Alain Fourquet, Bernard Asselain, et al.. (1994). Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. European Journal of Cancer. 30(5). 645–652. 337 indexed citations
10.
Rochefordière, Anne de la, F. Campana, J Fenton, et al.. (1993). Age as prognostic factor in premenopausal breast carcinoma. The Lancet. 341(8852). 1039–1043. 397 indexed citations
11.
Salmon, R, J.R. Vilcoq, J.C. Durand, et al.. (1992). Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Lancet. 339(8804). 1245–1248. 248 indexed citations
12.
Rochefordière, Anne de la, Bernard Asselain, François Campana, et al.. (1992). Breast cancer in premenopausal women : Is young age at diagnosis an independant prognostic factor?. International Journal of Radiation Oncology*Biology*Physics. 24. 221–221. 5 indexed citations
13.
Scholl, Suzy, Bernard Asselain, T Palangié, et al.. (1991). Neoadjuvant chemotherapy in operable breast cancer. European Journal of Cancer and Clinical Oncology. 27(12). 1668–1671. 82 indexed citations
15.
Campana, F., Philippe Vielh, Alain Fourquet, et al.. (1987). [Paget's disease of the nipple without any associated mammary tumor clinically or radiologically detectable. Apropos of 51 cases treated at the Curie Institute].. PubMed. 16(8). 1069–73. 6 indexed citations
16.
Haye, C, et al.. (1986). [Conservative treatment of tumors of the retina at the Curie Institute. 5-year ophthalmologic results of 129 cases treated with the Stallard disc and electrons].. PubMed. 73(3). 260–70. 2 indexed citations
17.
Thierry, Dominique, et al.. (1985). Human Blood Granulocyte Macrophage Progenitors (Gm-Cfu) During Extended Field Radiation Therapy. Acta Radiologica Oncology. 24(6). 521–526. 9 indexed citations
18.
Harris, Jay R., Abram Recht, R. Amalric, et al.. (1984). Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer.. Journal of Clinical Oncology. 2(1). 37–41. 89 indexed citations
19.
Vilcoq, J.R., R Calle, J.C. Durand, & Nemetallah Ā. Ghossein. (1981). Results of treatment of stage I breast cancer by tumorectomy and radiotherapy with and without axillary sampling. International Journal of Radiation Oncology*Biology*Physics. 7(9). 1219–1219. 1 indexed citations
20.
Pouillart, P, T Palangié, M Jouve, et al.. (1981). [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].. PubMed. 68(2). 171–86. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026